Cited by 1,425Brain Metastases and TreatmentManagement of metastatic bone diseaseCancer survivorship and care

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

Open access

Sperduto, Paul W., Kased, Norbert, Roberge, David, Xu, Zhiyuan, Shanley, Ryan, Luo, Xianghua, Sneed, Penny K., Chao, Samuel T., Weil, Robert J., Suh, John, Bhatt, Amit, Jensen, Ashley W., Brown, Paul D., Shih, Helen A., Kirkpatrick, John, Gaspar, Laurie E., Fiveash, John B., Chiang, Veronica, Knisely, Jonathan P.S., Sperduto, Christina Maria, Lin, Nancy, Mehta, Minesh·2012·Journal of Clinical Oncology

DOI 10.1200/jco.2011.38.0527PMC PMC3269967

Open this paper in CoChat — free account

Abstract

PURPOSE: Our group has previously published the Graded Prognostic Assessment (GPA), a prognostic index for patients with brain metastases. Updates have been published with refinements to create diagnosis-specific Graded Prognostic Assessment indices. The purpose of this report is to present the updated diagnosis-specific GPA indices in a single, unified, user-friendly report to allow ease of access and use by treating physicians. METHODS: A multi-institutional retrospective (1985 to 2007) database of 3,940 patients with newly diagnosed brain metastases underwent univariate and multivariate analyses of prognostic factors associated with outcomes by primary site and treatment. Significant prognostic factors were used to define the diagnosis-specific GPA prognostic indices. A GPA of 4.0 correlates with the best prognosis, whereas a GPA of 0.0 corresponds with the worst prognosis. RESULTS: Significant prognostic factors varied by diagnosis. For lung cancer, prognostic factors were Karnofsky performance score, age, presence of extracranial metastases, and number of brain metastases, confirming the original Lung-GPA. For melanoma and renal cell cancer, prognostic factors were Karnofsky performance score and the number of brain metastases. For breast cancer, prognostic factors were tumor subtype, Karnofsky performance score, and age. For GI cancer, the only prognostic factor was the Karnofsky performance score. The median survival times by GPA score and diagnosis were determined. CONCLUSION: Prognostic factors for patients with brain metastases vary by diagnosis, and for each diagnosis, a robust separation into different GPA scores was discerned, implying considerable heterogeneity in outcome, even within a single tumor type. In summary, these indices and related worksheet provide an accurate and facile diagnosis-specific tool to estimate survival, potentially select appropriate treatment, and stratify clinical trials for patients with brain metastases.

Integrity signals

Registry

Crossref · 10.1200/jco.2011.38.0527

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Classification and Regression Trees.
Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,858
Classification and Regression Trees.
Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 21,030
Cancer Statistics, 2008
Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184
Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trials
Gaspar, L. E., Scott, C., Rotman, M., Asbell, S. O., Phillips, T. L., Wasserman, T. H., McKenna, W. G., & Byhardt, R. W. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00619-0 · Cited by 2,548
Self-citation
A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database
Sperduto, P. W., Berkey, B. A., Gaspar, L. E., Mehta, M. P., & Curran, W. J. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.06.074 · Cited by 1,031
Self-citation
An Introduction to Recursive Partitioning Using the RPART Routines
Therneau, T. M., & Atkinson, E. J. (2015) · Cited by 1,006
Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients
Sperduto, P. W., Chao, S. T., Sneed, P. K., Luo, X., Suh, J. H., Roberge, D., Bhatt, A. K., Jensen, A. W., Brown, P. D., Shih, H. A., et al. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.08.025 · Cited by 987
Self-citation
Intracerebral metastases in solid-tumor patients: Natural history and results of treatment
Zimm, S., Wampler, G. L., Stablein, D., Hazra, T. A., & Young, H. F. (1981) · Cancer · doi:10.1002/1097-0142(19810715)48:2 · Cited by 597
Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases
Gaspar, L. E., Scott, C., Murray, K., & Curran, W. J. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00547-2 · Cited by 531
Self-citation
Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain Metastases
Sperduto, P. W., Kased, N., Roberge, D., Xu, Z., Shanley, R., Luo, X., Sneed, P. K., Chao, S. T., Weil, R. J., Suh, J. H., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.02.027 · Cited by 367
Self-citation

Flagged first, then by citations

Show all 21 references

Research works printed but not linked: 1

Therneau TM, 1997, Technical Report 61

Sorted by citations

Items 801–900 of 1,000

Stereotactic radiosurgery for brain metastases
Pikis, S., Protopapa, M., Mantziaris, G., Osama, M., & Sheehan, J. P. (2025) · Advances in cancer research · doi:10.1016/bs.acr.2025.04.001 · Cited by 8
Survival and Failure Outcomes Predicted by Brain Metastasis Volumetric Kinetics in Melanoma Patients Following Upfront Treatment with Stereotactic Radiosurgery Alone
LeCompte, M. C., McTyre, E., Henson, A. L., Farris, M. K., Okoukoni, C., Cramer, C. K., Triozzi, P. L., Ruiz, J., Watabe, K., Lo, H., et al. (2017) · Cureus · doi:10.7759/cureus.1934 · Cited by 8
Potential Prognostic Markers for Survival and Neurologic Death in Patients with Breast Cancer Brain Metastases who Receive upfront SRS Alone
Shenker, R. F., Hughes, R. T., McTyre, E., Lanier, C. M., Lo, H., Metheny‐Barlow, L. J., Thomas, A., Brown, D. R., Avery, T. P., Pasche, B., et al. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.07.926 · Cited by 8
Use of radiotherapy in breast cancer patients with brain metastases: a retrospective 11-year single center study
Gullhaug, A., Hjermstad, M. J., Yri, O. E., Svestad, J. G., Aass, N., & Johansen, S. (2021) · Journal of medical imaging and radiation sciences · doi:10.1016/j.jmir.2021.01.002 · Cited by 8
Outcomes following stereotactic radiosurgery or whole brain radiation therapy by molecular subtype of metastatic breast cancer
Haque, W. M., Verma, V., Adeberg, S., Rustomily, R., Lo, S. S.-M., Butler, E. B., & Teh, B. S. (2021) · Reports of Practical Oncology & Radiotherapy · doi:10.5603/rpor.a2021.0045 · Cited by 8
Five-Fraction Stereotactic Radiotherapy for Brain Metastases—A Retrospective Analysis
Layer, J. P., Layer, K., Sarria, G. R., Röhner, F., Dejonckheere, C. S., Friker, L. L., Zeyen, T., Koch, D., Scafa, D., Leitzen, C., et al. (2023) · Current Oncology · doi:10.3390/curroncol30020101 · Cited by 9
The association of health insurance with the survival of cancer patients with brain metastases at diagnosis
Kolomaya, A. E., Amin, S., & Lin, C. H. (2021) · Technical Innovations & Patient Support in Radiation Oncology · doi:10.1016/j.tipsro.2021.11.004 · Cited by 8
Diagnostic Value of 18F-FACBC PET/MRI in Brain Metastases
Øen, S. K., Johannessen, K., Pedersen, L. K., Berntsen, E. M., Totland, J. A., Johansen, H., Bogsrud, T. V., Solheim, T. S., Karlberg, A. M., & Eikenes, L. (2022) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000004435 · Cited by 8
The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy—Multicenter Italian–Polish Report
Placzke, J., Teterycz, P., Quaglino, P., Cybulska-Stopa, B., Tucci, M., Rubatto, M., Skóra, T., Internò, V., Rosinska, M., Borkowska, A. M., et al. (2022) · Cancers · doi:10.3390/cancers14235763 · Cited by 8
Risk factors and predictive models for early death in patients with advanced melanoma: A population-based study
Li, S., Yin, C., Yang, X., Lu, Y., Wang, C., & Liu, B. (2023) · Medicine · doi:10.1097/md.0000000000035380 · Cited by 8
Survival patterns following brain metastases for patients with melanoma in the MAP-kinase inhibitor era
Wattson, D. A., Sullivan, R. J., Niemierko, A., Merritt, R. M., Lawrence, D. P., Oh, K. S., Flaherty, K. T., & Shih, H. A. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1761-x · Cited by 8
Self-citation
Adding Bevacizumab to Chemotherapy Effectively Control Radioresistant Brain Metastases in ALK-Positive Lung Adenocarcinoma
Su, Y., & Rau, K. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000449 · Cited by 8
The Future of Targeted Therapies for Brain Metastases
Berghoff, A. S., & Preusser, M. (2015) · Future Oncology · doi:10.2217/fon.15.127 · Cited by 8
The effect of non-small cell lung cancer histology on survival as measured by the graded prognostic assessment in patients with brain metastases treated by hypofractionated stereotactic radiotherapy
Ma, L., Li, G., Zhang, H., Wang, Z., Dang, J., Zhang, S., & Yao, L. (2016) · Radiation Oncology · doi:10.1186/s13014-016-0667-x · Cited by 8
Brain Metastases and Neoplastic Meningitis
Sneed, P. K., Kased, N., & Rubenstein, J. L. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00050-3 · Cited by 8
Self-citation
Beyond breast specific—Graded Prognostic Assessment in patients with brain metastases from breast cancer: treatment impact on outcome
Griguolo, G., Dieci, M. V., Giarratano, T., Giorgi, C. A., Orvieto, E., Ghiotto, C., Berti, F., Puppa, A. D., Falci, C., Mioranza, E., et al. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2309-4 · Cited by 8
Predicting brain metastases for non-small cell lung cancer based on magnetic resonance imaging
Yin, G., Li, C., Chen, H., Luo, Y., Orlandini, L. C., Wang, P., & Lang, J. (2017) · Clinical & Experimental Metastasis · doi:10.1007/s10585-016-9833-7 · Cited by 8
Outcomes of Surgery followed by Local Brain Radiotherapy Compared with Surgery followed by Whole Brain Radiotherapy for Single Brain Metastasis
Igaki, H., Harada, K., Umezawa, R., Miyakita, Y., Ohno, M., Takahashi, M., Sumi, M., Inaba, K., Murakami, N., Ito, Y., et al. (2017) · Tumori Journal · doi:10.5301/tj.5000657 · Cited by 8
Long-Term Survivorship Following Stereotactic Radiosurgery Alone for Brain Metastases: Risk of Intracranial Failure and Implications for Surveillance and Counseling
Gogineni, E., Vargo, J. A., Glaser, S., Flíckinger, J. C., Burton, S. A., Engh, J. A., Amankulor, N. M., Beriwal, S., Quinn, A. E., Ozhasoglu, C., et al. (2017) · Neurosurgery · doi:10.1093/neuros/nyx376 · Cited by 8
Validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: extra-cranial disease progression is an independent risk factor
Zhuang, Q., Wong, R. X., Lian, W., Li, Y. Q., & Wong, F. Y. (2019) · Annals of Palliative Medicine · doi:10.21037/apm.2019.02.05 · Cited by 8
Hypofractionated stereotactic radiotherapy for challenging brain metastases using 36 Gy in six fractions
Lecomte, D. D., Lequesne, J., Geffrelot, J., Lesueur, P., Barraux, V., Loiseau, C., Lacroix, J., Leconte, A., Emery, É., Thariat, J., et al. (2019) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2019.06.012 · Cited by 8
Prognostic impact of platinum sensitivity in ovarian carcinoma patients with brain metastasis
da Costa, A. A. B. A., Santos, E. S. D., Cotrim, D. P., Pandolfi, N. C., Cesca, M. G., Mantoan, H., Sanches, S. M., Ribeiro, A. R. G., Brot, L. D., Bonvolim, G., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-6382-x · Cited by 8
External Validation of a Prognostic Score for Patients with Brain Metastases: Extended Diagnosis-Specific Graded Prognostic Assessment
Nieder, C., Hess, S., & Lewitzki, V. (2020) · Oncology Research and Treatment · doi:10.1159/000506954 · Cited by 8
Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases
Rahimy, E., Dudley, S. A., von Eyben, R., Pollom, E. L., Seiger, K., Modlin, L. A., Wynne, J. F., Fujimoto, D. K., Jacobs, L. R., Chang, S. D., et al. (2021) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000868 · Cited by 8
Clinical Feasibility of Ultrafast Contrast-Enhanced T1-Weighted 3D-EPI for Evaluating Intracranial Enhancing Lesions in Oncology Patients: Comparison with Standard 3D MPRAGE Sequence
Ryu, K. H., Baek, H. J., Skare, S. T., Cho, E., Nam, I. C., Kim, T. H., & Sprenger, T. (2022) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7391 · Cited by 8
A study of non small cell lung cancer (NSCLC) patients with brain metastasis: A single centre experience
Hatton, N. L. F., Samuel, R. J., Riaz, M., Johnson‐Hart, C., Cheeseman, S., & Snee, M. (2022) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2022.100673 · Cited by 8
The Energy Index Does Not Affect Local Control of Brain Metastases Treated by Gamma Knife Stereotactic Radiosurgery
Jani, A., Rozenblat, T., Yaeh, A. M., Nanda, T., Saad, S., Qureshi, Y. H., Feng, W., Sisti, M. B., Bruce, J. N., McKhann, G. M., et al. (2015) · Neurosurgery · doi:10.1227/neu.0000000000000750 · Cited by 8
Prognostic Value of Brain Metastasis-Free Interval in Patients with Breast Cancer Brain Metastases
Hulsbergen, A. F. C., Lamba, N., Claes, A., Kavouridis, V. K., Lin, N., Smith, T. R., Verhoeff, J. J. C., & Broekman, M. L. D. (2019) · World Neurosurgery · doi:10.1016/j.wneu.2019.04.072 · Cited by 8
Self-citation
Stereotactic radiosurgery in the treatment of brain metastases from gynecologic primary cancer.
Johnston, H. E., McTyre, E., Cramer, C. K., Lesser, G. J., Ruiz, J., Bourland, J. D., Watabe, K., Lo, H., Qasem, S. A., Laxton, A. W., et al. (2017) · Europe PMC (PubMed Central) · Cited by 8
Is Graded Prognostic Assessment an Improvement Compared With Radiation Therapy Oncology Group's Recursive Partitioning Analysis Classification for Brain Metastases?
Chamberlain, M. C., & Silbergeld, D. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.6429 · Cited by 8
Whole Brain Radiotherapy for Brain Metastases
Kaidar‐Person, O., Anders, C. K., & Zagar, T. M. (2016) · JAMA · doi:10.1001/jama.2016.8692 · Cited by 8
The role of systemic and targeted therapies in brain metastases
Franceschi, E., Bartolotti, M., Poggi, R., Battista, M. D., Palleschi, D., & Brandes, A. A. (2014) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.2014.856760 · Cited by 7
Targeting EGFR Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer: Changes in Treatment Strategies are Coming
Liu, H., Qin, J., & Qian, X. (2024) · Cancer Control · doi:10.1177/10732748241292782 · Cited by 8
Clinical factors associated with mortality within three months after radiosurgery of asymptomatic brain metastases from non-small cell lung cancer
Kakusa, B. W., Han, S. S., Aggarwal, S., Liu, B., Li, G., Soltys, S. G., & Gephart, M. H. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-03002-0 · Cited by 7
Cost-effectiveness analysis of 3 radiation treatment strategies for patients with multiple brain metastases
Chen, V. E., Kim, M., Nelson, N. G., Kim, I. K., & Shi, W. (2022) · Neuro-Oncology Practice · doi:10.1093/nop/npac093 · Cited by 7
MR imaging profile and histopathological characteristics of tumour vasculature, cell density and proliferation rate define two distinct growth patterns of human brain metastases from lung cancer
Kiyose, M., Herrmann, E. M., Roesler, J., Zeiner, P. S., Steinbach, J. P., Forster, M.-T., Plate, K. H., Czabanka, M., Vogl, T. J., Hattingen, E., et al. (2022) · Neuroradiology · doi:10.1007/s00234-022-03060-2 · Cited by 7
Fractionated stereotactic radiotherapy of brain metastases: results of a retrospective study
Gruber, I., Stark, P., Weidner, K., Treutwein, M., & Koelbl, O. (2023) · Radiation Oncology · doi:10.1186/s13014-023-02277-6 · Cited by 7
Different profiles of neurocognitive functioning in patients with brain metastases prior to brain radiotherapy
van Grinsven, E. E., Cialdella, F., Verhoeff, J. J. C., Philippens, M. E. P., & van Zandvoort, M. J. E. (2023) · Psycho-Oncology · doi:10.1002/pon.6229 · Cited by 7
Evaluating the atherosclerosis cardiovascular disease risk score in patients with brain metastases: Associations with overall survival and high-value care outcomes
Kazemi, F., Liu, J., Parker, M., Robinaugh, J., Ahmed, A. K., Rincón-Torroella, J., Jackson, C. M., Gallia, G. L., Bettegowda, C., WEINGART, J. D., et al. (2024) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2024.108549 · Cited by 7
Hybrid Deep Learning for Survival Prediction in Brain Metastases Using Multimodal MRI and Clinical Data
Volovăț, C. C., Buzea, C. G., Boboc, D.-I., Ostafe, M.-R., Agop, M., Ochiuz, L., Burlea, Ș. L., Rusu, D. I., Bujor, L., Iancu, D. T., et al. (2025) · Diagnostics · doi:10.3390/diagnostics15101242 · Cited by 8
Treatment of brain metastases in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations: the role of EGFR tyrosine kinase inhibitors.
Karachaliou, N., & Rosell, R. (2013) · PubMed · doi:10.3978/j.issn.2224-5820.2013.05.02 · Cited by 7
Cranial irradiation in patients with EGFR-mutant non-small cell lung cancer brain metastases.
Yang, J. T., & Wu, A. J.-C. (2016) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2016.01.08 · Cited by 7
Hirnmetastasen und Meningeosis neoplastica
Weller, M., Schlegel, U. S., & Schachert, G. (2015) · Elsevier eBooks · doi:10.1016/b978-3-437-22107-1.50342-3 · Cited by 7
Computed tomography-magnetic resonance imaging fusion-guided iodine-125 seed implantation for single malignant brain tumor: Feasibility and safety
Hu, X., Liu, S.-F., Lu, J., Wang, H., Han, Y., Wang, D., Yang, L., & Li, Z. (2019) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_70_19 · Cited by 7
A Contemporary Report of Clinical Outcomes in Patients with Melanoma Brain Metastases
Phillips, W. J., Baghai, T., Ong, M., Lo, B., Ibrahim, A. M., Smith, T. K. T., & Song, X. (2021) · Current Oncology · doi:10.3390/curroncol28010045 · Cited by 7
Androgen Receptor is Expressed in Breast Cancer Brain Metastases
Bergen, E. S., Berghoff, A. S., Steindl, A., Rajky, O., Mercea, P. A., Kiesel, B., Tendl-Schulz, K., Bagó-Horváth, Z., Exner, R., Fitzal, F., et al. (2021) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000952 · Cited by 7
Brain Metastases: Patient-Reported Outcome and Quality of Life after Whole-Brain Radiotherapy
Otto-Vollaard, L., Quint, S., de Pree, I. M. N., Steinvoort-Draat, I. N., Tims, O., & Nuyttens, J. J. M. E. (2022) · Journal of Palliative Medicine · doi:10.1089/jpm.2021.0533 · Cited by 7
Improved Survival With Surgical Treatment of Primary Lung Lesions in Non-Small Cell Lung Cancer With Brain Metastases: A Propensity‐Matched Analysis of Surveillance, Epidemiology, and End Results Database
Wang, Q., Li, J., Liang, X., & Zhan, Q. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.888999 · Cited by 7
A 3-month survival model after Gamma Knife surgery in patients with brain metastasis from lung cancer with Karnofsky performance status ≤ 70
Park, H., Chung, H., Kim, J., Dho, Y., & Lee, E. J. (2023) · Scientific Reports · doi:10.1038/s41598-023-40356-6 · Cited by 7
Local hero: A phase II study of local therapy only (stereotactic radiosurgery and / or surgery) for treatment of up to five brain metastases from HER2+ breast cancer. (TROG study 16.02)
Phillips, C., Pinkham, M. B., Moore, A., Sia, J., Jeffree, R. L., Khasraw, M., Kam, A. W., Bressel, M., & Haworth, A. (2024) · The Breast · doi:10.1016/j.breast.2024.103675 · Cited by 7
Survival of patients with multiple brain metastases treated with whole-brain radiotherapy
Wong, E., Tsao, M. N., Zhang, L., Danjoux, C. E., Barnes, E. A., Pulenzas, N., Vuong, S., & Chow, E. (2015) · CNS Oncology · doi:10.2217/cns.15.17 · Cited by 7
An unusual pituitary stalk lesion: What is the place of surgery?
Todeschi, J., Chibbaro, S., Clavier, J.-B., Lhermitte, B., Goichot, B., & Proust, F. (2016) · Neurochirurgie · doi:10.1016/j.neuchi.2016.08.002 · Cited by 7
Defining the endpoints: how to measure the efficacy of drugs that are active against central nervous system metastases
Fabi, A., & Vidiri, A. (2016) · Translational Lung Cancer Research · doi:10.21037/tlcr.2016.11.02 · Cited by 7
Achievements and future developments of ALK-TKIs in the management of CNS metastases from ALK-positive NSCLC
Landi, L. M., & Cappuzzo, F. (2016) · Translational Lung Cancer Research · doi:10.21037/tlcr.2016.12.05 · Cited by 8
The Demise of Whole-Brain Radiation Therapy
Urbanic, J. J. (2017) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2017.08.040 · Cited by 7
Radiological Kinetics of Brain Metastases and Clinical Implications for Patients Treated With Stereotactic Radiosurgery
Nicholls, L., Pinkham, M. B., Bernard, A., Lusk, R., Watkins, T. W., Hall, B. I., Olson, S., & Foote, M. C. (2018) · Clinical Oncology · doi:10.1016/j.clon.2018.09.005 · Cited by 8
Prognostic factors and survival in Japanese patients with brain metastasis from renal cell cancer
Takeshita, N., Otsuka, M., Kamasako, T., Somoto, T., Uemura, T., Shinozaki, T., Kobayashi, M., Kawana, H., Itami, M., Iuchi, T., et al. (2019) · International Journal of Clinical Oncology · doi:10.1007/s10147-019-01474-2 · Cited by 7
Outcome of Omani Women with Breast Cancer-associated Brain Metastases Experience from a University Hospital
Zahid, K. F., Kumar, S., Al-Bimani, K., Ahmed, T., Al-Ajmi, A., Burney, I. A., & Al-Moundhri, M. S. (2019) · Oman Medical Journal · doi:10.5001/omj.2019.76 · Cited by 7
Stereotactic radiosurgery for the treatment of brain metastasis from gastrointestinal primary cancers.
Paudel, N., Helenowski, I., Kane, L., Sachdev, S., Bloch, O. G., Tate, M. C., Chandler, J. P., & Kruser, T. J. (2019) · Europe PMC (PubMed Central) · Cited by 7
Clinical Characteristics and Therapeutic Outcomes of Metastatic Peritoneal Carcinomatosis in Non-Small-Cell Lung Cancer
Tani, T., Nakachi, I., Ikemura, S., Nukaga, S., Ohgino, K., Kuroda, A., Terai, H., Masuzawa, K., Shinozaki, T., Ishioka, K., et al. (2021) · Cancer Management and Research · doi:10.2147/cmar.s330103 · Cited by 7
Phase II Study of Nivolumab Plus Ipilimumab with Platinum-Based Chemotherapy for Treatment-Naïve Advanced Non-Small Cell Lung Cancer with Untreated Brain Metastases: NIke Trial (LOGiK2004)
Tsuchiya‐Kawano, Y., Shiraishi, Y., Kiyomi, F., & Okamoto, I. (2021) · Cancer Management and Research · doi:10.2147/cmar.s341287 · Cited by 7
Added survival benefit of whole brain radiotherapy in brain metastatic non-small cell lung cancer: Development and external validation of an individual prediction model
Trikhirhisthit, K., Setakornnukul, J., & Thephamongkhol, K. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.911835 · Cited by 7
Elevated Radiation Therapy Toxicity in the Setting of Germline PTEN Mutation
Tatebe, K., Chmura, S. J., & Connell, P. P. (2019) · Practical Radiation Oncology · doi:10.1016/j.prro.2019.06.001 · Cited by 7
Radiotherapy of brain metastases from small-cell lung cancer: standards and controversies
Kępka, L. (2019) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2018.114 · Cited by 7
The neurocognitive function change criteria after whole-brain radiation therapy for brain metastasis, in reference to health-related quality of life changes: a prospective observation study
Nakano, T., Aoyama, H., Saito, H., Tanabe, S., Tanaka, K., Maruyama, K., Oshikane, T., Ohta, A., Abe, E., & Kaidu, M. (2020) · BMC Cancer · doi:10.1186/s12885-020-6559-3 · Cited by 7
Survival time and prognostic factors after whole-brain radiotherapy of brain metastases from of breast cancer
Okada, Y., Kobayashi, M., Shinozaki, M., Abe, T., Kanemaki, Y., Nakamura, N., & Kojima, Y. (2020) · Acta Radiologica Open · doi:10.1177/2058460120938744 · Cited by 7
Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases
Wang, J., Liu, Z., Pang, Q., Zhang, T., Chen, X., Er, P., Wang, P., Wang, P., & Wang, J. (2020) · BMC Cancer · doi:10.1186/s12885-020-07249-7 · Cited by 7
Tumors of the Central Nervous System
Gray, P. J., Loeffler, J. S., & Shih, H. A. (2017) · Wiley eBooks · doi:10.1002/9781119341154.ch39 · Cited by 7
Self-citation
Imaging and Clinical End Points in Brain Metastases Trials
Soffietti, R., Chiavazza, C., & Rudà, R. (2017) · CNS Oncology · doi:10.2217/cns-2017-0017 · Cited by 7
Outcomes in Patients with Non-Small-Cell Lung Cancer with Brain Metastases: A Real-World Data Study from a Resource-Limited Country
Randjelović, N., Petronijevic, M., Calamac, M., Peulic, M., Filipovic, B., Mutavdzic, V., Djurić, A., Rankovic, T., Bugarcic, M., Canak, I., et al. (2025) · Cancers · doi:10.3390/cancers17101603 · Cited by 6
Survival and prognostic factors of HER2-mutant advanced non-small cell lung cancer with brain metastases
Zhang, Q., Yang, Y., Xie, M., Zhou, Z., Wu, H., Zhai, W., Chen, Y., Chen, K., Zhou, S., Li, H., et al. (2025) · Lung Cancer · doi:10.1016/j.lungcan.2025.108616 · Cited by 6
Prognostic Factors in Thyroid Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis
Salim, H. A., Msherghi, A. A. A., Learned, K. O., Zafereo, M., Wang, J. R., Dagher, R., Taşlıçay, C. A., Dagher, R., Alizada, S., Hu, M. I.-N., et al. (2025) · Thyroid · doi:10.1177/10507256251372639 · Cited by 6
Sensitizing brain metastases to stereotactic radiosurgery using hyperbaric oxygen: A proof-of-principle study
Hartford, A. C., Gill, G. S., Ravi, D., Tosteson, T. D., Li, Z., Russo, G. A., Eskey, C. J., Jarvis, L. A., Simmons, N. E., Evans, L. T., et al. (2022) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2022.10.024 · Cited by 6
Multimodal Treatments for Brain Metastases from Renal Cell Carcinoma: Results of a Multicentric Retrospective Study
Navarria, P., Pessina, F., Minniti, G. C., Franzese, C., Marini, B., D’Agostino, G. R., Badalamenti, M., Raspagliesi, L., Reggiori, G., Lobefalo, F., et al. (2023) · Cancers · doi:10.3390/cancers15051393 · Cited by 6
Characterization of patients with brain metastases referred to palliative care
Harrison, R. A., Tang, M. J., Shih, K. K., Khan, M. R., Pham, L., de Moraes, A. R., O'Brien, B. J., Bassett, R. L., & Bruera, E. D. (2024) · BMC Palliative Care · doi:10.1186/s12904-023-01320-3 · Cited by 7
Current pharmacologic treatment of brain metastasis in non-small cell lung cancer
Okuno, T., Isobe, T., & Tsubata, Y. (2024) · Clinical & Experimental Metastasis · doi:10.1007/s10585-024-10276-4 · Cited by 6
Individualized trajectories in postradiotherapy neurocognitive functioning of patients with brain metastases
van Grinsven, E. E., Cialdella, F., Meijling, Y. A. G., Verhoeff, J. J. C., Philippens, M. E. P., & van Zandvoort, M. J. E. (2024) · Neuro-Oncology Practice · doi:10.1093/nop/npae024 · Cited by 6
Blood Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Promising Screening Biomarkers for Brain Metastases in Patients with Lung Cancer
Kim, S., Ahn, B., Lee, D.-E., Kim, K. H., Hyun, J., Kim, M. J., Park, N. Y., Kim, H. J., & Lee, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126397 · Cited by 6
Application of random survival forest to establish a nomogram combining clinlabomics-score and clinical data for predicting brain metastasis in primary lung cancer
Shi, Z., Chen, Y., Liu, A., Zeng, J., Xie, W., Lin, X., Cheng, Y., Xu, H., Zhou, J., Gao, S., et al. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03688-x · Cited by 6
Combination therapy of adagrasib and abemaciclib in non-small cell lung cancer brain metastasis models genomically characterized by KRAS-G12C and homozygous loss of CDKN2A
Migliarese, C., Sadeh, Y., Torrini, C., Demir, F. T., Nayyar, N., Yamazawa, E., Ishikawa, Y., Ijad, N., Summers, E., Elliott, A., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-01993-2 · Cited by 6
Is Anlotinib and Radiotherapy Combination Effective for Non-Small-Cell Lung Cancer with Brain Metastases? A Systematic Scoping Review and Meta-Analysis
Hetta, ‏. F., Ali, M. A. S., Alqifari, S. F., Salem, H. A., Qasem, K. A., Alanazi, F. E., Alhowiti, A., Alatawi, A. M., Mirghani, H. O., Alrasheed, T., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18070974 · Cited by 6
Evaluation of the Effect of Lymph Node Status on the Survival of Non-Small Cell Lung Cancer Patients With Brain Metastases: Applications of a Novel Grade Prognostic Assessment Score Model Involving N Stage
Zhu, J., Wang, W., Xu, S., Jia, C., Zhang, Q., Xia, Y., Wang, W., Wen, M., Wang, X., Wang, H., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.563700 · Cited by 6
Stereotactic Radiosurgery of Brain Metastasis in Patients with a Poor Prognosis: Effective or Overtreatment?
Harat, M., Blok, M., Miechowicz, I., & Kowalewska, J. (2020) · Cancer Management and Research · doi:10.2147/cmar.s272369 · Cited by 6
Validation and comparison of Breast Graded Prognostic Assessment scores in patients with breast cancer and brain metastases
Fabregat-Franco, C., Stradella, A., Navarro, V., Linares, J., Galdeano, M., Recalde, S., Velasco, R., Simó, M., Fernádez, A., Venthecourt, A. C., et al. (2021) · Clinical & Translational Oncology · doi:10.1007/s12094-021-02577-x · Cited by 6
Prediction of Short and Long Survival after Surgery for Breast Cancer Brain Metastases
Michel, A., Oppong, M. D., Rauschenbach, L., Dinger, T. F., Barthel, L., Pierscianek, D., Wrede, K. H., Hense, J., Pöttgen, C., Junker, A., et al. (2022) · Cancers · doi:10.3390/cancers14061437 · Cited by 6
ADC textural features in patients with single brain metastases improve clinical risk models
Nowosielski, M., Goebel, G., Iglseder, S., Steiger, R., Ritter, L., Stampfl, D., Heugenhauser, J., Kerschbaumer, J., Gizewski, E. R., Freyschlag, C. F., et al. (2022) · Clinical & Experimental Metastasis · doi:10.1007/s10585-022-10160-z · Cited by 7
Prognostic assessment in patients operated for brain metastasis from systemic tumors
Grossenbacher, B., Lareida, A., Moors, S., Roth, P., Kulcsár, Z., Regli, L., Rhun, É. L., Weller, M., & Wolpert, F. (2023) · Cancer Medicine · doi:10.1002/cam4.5928 · Cited by 6
Palliative whole brain radiation therapy: an international state of practice
Keit, E., Lee, S. F., Woodward, M., Rembielak, A., Shiue, K., Desideri, I., Oldenburger, E., Bienz, M., Rades, D., Theodorou, M., et al. (2023) · Annals of Palliative Medicine · doi:10.21037/apm-23-448 · Cited by 6
Perilesional edema diameter associated with brain metastases as a predictive factor of response to radiotherapy in non-small cell lung cancer
Arrieta, O. G., Bolaño-Guerra, L. M., Caballé‐Perez, E., Lara‐Mejía, L., Turcott, J. G., Gutiérrez, S., Lozano-Ruiz, F. J., Cabrera-Miranda, L. A., Arroyave-Ramírez, A. M., Maldonado‐Magos, F., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1251620 · Cited by 6
A new paradigm in treatment of brain metastases
McDonald, M. W., & McMullen, K. P. (2015) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2015.03.001 · Cited by 6
3D Radiation Therapy Boost Improves the Outcome of Whole Brain Radiation Therapy Treated RPA II Patients with One or Two Brain Metastases
Antoni, D., Clavier, J.-B., Pop, M., Schumacher, C., Lefèbvre, F., & Noël, G. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15057554 · Cited by 6
Brain metastases in patients under 50 years of age: retrospective analysis
Nieder, C., Grosu, A., Spanne, O., Andratschke, N. H., & Geinitz, H. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9484-2 · Cited by 6
Improving brain penetration of kinase inhibitors in lung cancer patients with oncogene dependency
Remón, J., & Soria, J. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw553 · Cited by 6
An update on radiation therapy for brain metastases
Lam, T., Sahgal, A., Lo, S. S.-M., & Chang, E. L. (2017) · Chinese Clinical Oncology · doi:10.21037/cco.2017.06.02 · Cited by 7
Resection cavity radiosurgery for intracranial metastases: a review of the literature.
Zhang, Y., & Chang, E. L. (2014) · Europe PMC (PubMed Central) · Cited by 6
Radiotherapy of brain metastases from non-small cell lung cancer
Kıraklı, E. K., & Yılmaz, U. (2019) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2018.73 · Cited by 6
Impact of pre-OP independence in patients with limited brain metastases on long-term survival
Bleckmann, A., Kirchner, B., Nietert, M. M., Peeck, M., Balkenhol, M., Egert, D., Rohde, T. V., Beißbarth, T., & Pukrop, T. (2020) · BMC Cancer · doi:10.1186/s12885-020-07459-z · Cited by 6
Survival Benefit from Surgical Resection in Lung Cancer Patients with Brain Metastases: a Single-Center, Propensity-Matched Analysis Cohort Study
Wang, Z.-N., Jiang, X., Lü, J., Guo, X., He, Z., Duan, H., Liang, L., Cui, R., Hu, H., Zhang, X., et al. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-022-11365-y · Cited by 6
Combined Primary Tumor and Extracranial Metastasis Status as Constituent Factor of Prognostic Indices for Predicting the Overall Survival in Patients with Brain Metastases
Park, Y., Kim, T. H., Jung, S., Kim, Y., Bae, J., Kim, Y.-J., Choi, J., Lee, N. K., Moon, S. H., Kim, S. S., et al. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.2.205 · Cited by 6
Brain Metastasis
Murrell, D. H., Perera, F. E., Chambers, A. F., & Foster, P. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804003-4.00017-7 · Cited by 6

Authors: Sperduto, P. W., Kased, N., Roberge, D., Xu, Z., Shanley, R., Luo, X., Sneed, P. K., Chao, S. T., Weil, R. J., Suh, J., Bhatt, A., Jensen, A. W., Brown, P. D., Shih, H. A., Kirkpatrick, J., Gaspar, L. E., Fiveash, J. B., Chiang, V., Knisely, J. P. S., Sperduto, C. M., Lin, N., & Mehta, M.
Affiliations: University of Minnesota (US)
University of California, San Francisco (US)
McGill University (CA)
Cleveland Clinic (US)
Author affiliations appear at the end of this article.
Mayo Clinic (US)
Harvard University (US)
Duke University (US)
University of Colorado Denver (US)
University of Alabama at Birmingham (US)
Yale University (US)
Hofstra University (US)
Dartmouth College (US)
Northwestern University (US)
ORCID: Sperduto, Paul W.
Kased, Norbert
Roberge, David
Xu, Zhiyuan
Shanley, Ryan
Luo, Xianghua
Sneed, Penny K.
Chao, Samuel T.
Weil, Robert J.
Suh, John
Bhatt, Amit
Brown, Paul D.
Shih, Helen A.
Kirkpatrick, John
Fiveash, John B.
Chiang, Veronica
Knisely, Jonathan P.S.
Mehta, Minesh
Venue: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Published: 2012-02-01
Volume: 30
Issue: 4
Pages: 419-425
ISSN: 0732-183X (ISSN-L)
1527-7755
DOI: 10.1200/jco.2011.38.0527
PMC: PMC3269967
OpenAlex: W1974820090
Cited by: 1,425
References: 21
Citations by year: 2026: 41 · 2025: 57 · 2024: 88 · 2023: 112 · 2022: 103 · 2021: 113 · 2020: 146 · 2019: 117 · 2018: 131 · 2017: 134 · 2016: 115 · 2015: 94 · 2014: 68 · 2013: 62 · 2012: 38
FWCI: 45.80
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Journal of Clinical Oncology (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (P30CA-77598, P30CA077598)
Topics: Health Sciences › Medicine › Oncology › Brain Metastases and Treatment
Health Sciences › Medicine › Surgery › Management of metastatic bone disease
Health Sciences › Medicine › Oncology › Cancer survivorship and care
Keywords: brain metastases, Graded Prognostic Assessment, prognosis, survival estimation, prognostic factors, lung cancer, melanoma, renal cell carcinoma, breast cancer, gastrointestinal cancer, Karnofsky performance status, extracranial metastases, number of brain metastases, clinical trial stratification
MeSH terms: Brain Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Female, Humans, Kidney Neoplasms, Lung Neoplasms, Male, Melanoma, Neoplasm Metastasis, Prognosis, Retrospective Studies, Survival Analysis, Neoplasm Grading

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks